BeOne Medicines AG
OTC:BEIGF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
BeOne Medicines AG
OTC:BEIGF
|
CH |
|
E
|
Electromagnetic Geoservices ASA
F:E2M
|
NO |
|
AML3D Ltd
F:4YP
|
AU |
|
Chemometec A/S
CSE:CHEMM
|
DK |
|
E
|
Electromagnetic Geoservices ASA
XMUN:E2M
|
NO |
Wall St Price Targets
BEIGF Price Targets Summary
BeOne Medicines AG
According to Wall Street analysts, the average 1-year price target for BEIGF is 32.01 USD with a low forecast of 26.715 USD and a high forecast of 41.268 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BEIGF's stock price target?
Price Target
32.01
USD
According to Wall Street analysts, the average 1-year price target for BEIGF is 32.01 USD with a low forecast of 26.715 USD and a high forecast of 41.268 USD.
What is the Revenue forecast for BeOne Medicines AG?
Projected CAGR
11%
Over the last 6 years, the compound annual growth rate for Revenue has been 53%. The projected CAGR for the next 8 years is 11%.
What is the Gross Profit forecast for BeOne Medicines AG?
Projected CAGR
10%
Over the last 6 years, the compound annual growth rate for Gross Profit has been 54%. The projected CAGR for the next 6 years is 10%.
What is the Operating Income forecast for BeOne Medicines AG?
Projected CAGR
33%
The compound annual growth rate for Operating Income over the next 8 years is 33%.
What is the Pre-Tax Income forecast for BeOne Medicines AG?
Projected CAGR
73%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 73%.
What is the Net Income forecast for BeOne Medicines AG?
Projected CAGR
45%
The compound annual growth rate for Net Income over the next 8 years is 45%.